PATENT CLAIM ANALYSIS

Application Number: 15742947
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "415000"]

Abstract:
Indoline and tetrahydroquinoline sulfonyl compounds that can inhibit DapE and/or bacterial metallo-62 -lactamases (“MBLs”), such as NDM-1 are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the compounds disclosed herein.

Claim (Index 3):
The compound of  claim 1  or  2 , wherein m is 1.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.15789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15501489', '10851428', '15323081', '10888849', '14146643']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604272827985079
- 35 USC 102 Novelty (BERT): 0.5062900939098118
- Combined Prediction Score: 0.7350135639096382
- Mean Citation Score: 231.8951
- Max Citation Score: 258.33267
- Similarity Product: 182.46400393112185

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test